Cite
HARVARD Citation
Tolley, E. et al. (2019). Acceptability of a long‐acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076). Journal of the International AIDS Society. 22 (10), p. n/a. [Online].